Crossref
Dapagliflozin: Beneficial Effects Beyond Glycaemia
International Journal of Diabetes Management · 2021
DOI: 10.61797/ijdm.v1i1.63 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Diabetes Management, 2021. Verfasst von Nikolaos Papanas und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Papanas, N., & Popovic, D. S. (2021). Dapagliflozin: Beneficial Effects Beyond Glycaemia. International Journal of Diabetes Management. https://doi.org/10.61797/ijdm.v1i1.63
Vancouver
Papanas N, Popovic DS. Dapagliflozin: Beneficial Effects Beyond Glycaemia. International Journal of Diabetes Management. 2021. doi:10.61797/ijdm.v1i1.63
BibTeX
@article{Papanas2021,
author = {Papanas, Nikolaos and Popovic, Djordje S},
title = {Dapagliflozin: Beneficial Effects Beyond Glycaemia},
journal = {International Journal of Diabetes Management},
year = {2021},
doi = {10.61797/ijdm.v1i1.63}
}
EUVIMED